Variant report
Variant | esv1824297 |
---|---|
Chromosome Location | chr3:163725664-163729755 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs557810236 | chr3:163725673-163725674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs186088381 | chr3:163725701-163725702 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs34566460 | chr3:163725703-163725704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs189480394 | chr3:163725709-163725710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs540311995 | chr3:163725791-163725792 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs181949670 | chr3:163725831-163725832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs529059898 | chr3:163725849-163725850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs7626982 | chr3:163725853-163725854 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs562408872 | chr3:163725904-163725905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs367632742 | chr3:163725957-163725958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs547158104 | chr3:163725995-163725996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs531523002 | chr3:163726032-163726033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs550513886 | chr3:163726079-163726080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs570522816 | chr3:163726154-163726155 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs7643223 | chr3:163726233-163726234 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs547068409 | chr3:163726246-163726247 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs73876531 | chr3:163726267-163726268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs149589452 | chr3:163726352-163726353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs555700770 | chr3:163726356-163726357 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs10936387 | chr3:163726357-163726358 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs186145720 | chr3:163726369-163726370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs562726129 | chr3:163726445-163726446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs190670193 | chr3:163726528-163726529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs549130409 | chr3:163726532-163726533 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs567623441 | chr3:163726535-163726536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs538238391 | chr3:163726599-163726600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs146113628 | chr3:163726633-163726634 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs182738319 | chr3:163726656-163726657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs79239263 | chr3:163726708-163726709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs114506352 | chr3:163726745-163726746 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs542778971 | chr3:163726780-163726781 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs562345210 | chr3:163726820-163726821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs73168240 | chr3:163726840-163726841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs575891151 | chr3:163726852-163726853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs544894257 | chr3:163726902-163726903 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186492788 | chr3:163726906-163726907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs190060903 | chr3:163726908-163726909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs546714492 | chr3:163726926-163726927 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs560602418 | chr3:163726946-163726947 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs528741225 | chr3:163726974-163726975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs529392026 | chr3:163726976-163726977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs549509624 | chr3:163727000-163727001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Bladder cancer | 21909424 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Cancer | 20164919 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:163724800-163727000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |